Trials / Conditions / Astrocytoma, Grade III

Astrocytoma, Grade III

15 registered clinical trials studyying Astrocytoma, Grade III — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent M NCT06614855	James Markert, MD	Phase 1
Recruiting	Study of Olutasidenib and Temozolomide in HGG NCT06161974	Rigel Pharmaceuticals	Phase 2
Recruiting	A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Gli NCT05765812	Debiopharm International SA	Phase 1 / Phase 2
Recruiting	The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 220 NCT06118723	Jasper Gerritsen	—
Completed	Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma NCT04757662	Washington University School of Medicine	Phase 1
Completed	Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma NCT03450850	Daniela A. Bota	N/A
Completed	Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes NCT04304300	Erasmus Medical Center	—
Terminated	FORWARD Optune and Adjuvant TMZ in Grade II/III Astrocytoma NCT03906448	University of Florida	Phase 2
Withdrawn	Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas NCT03956706	Northwell Health	N/A
Completed	Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 NCT02655601	BioMimetix JV, LLC	Phase 1 / Phase 2
Completed	Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astro NCT03224104	European Organisation for Research and Treatment of Cancer - EORTC	Phase 1
Recruiting	HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM NCT03596086	David Baskin MD	Phase 1 / Phase 2
Completed	Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma NCT03072134	Northwestern University	Phase 1
Terminated	Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine NCT02722512	Ann & Robert H Lurie Children's Hospital of Chicago	Phase 1
Completed	Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors NCT02644291	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 1